The 19 member companies of the Medicon Valley Inhalation Consortium (MVIC) have announced the creation of a single company called MVIC AB in order to simplify customer relationships with the organization. Orest Lastow of Zenit Design, who founded the consortium, will be CEO. MVIC AB has 2 GMP facilities and provides a full range of inhalation product services, including drug discovery, characterization, formulation and device development, deposition studies, regulatory affairs, and manufacturing.
According to MVIC, its 60 inhalation experts have a total of 800 years of experience at companies like AstraZeneca and Novo Nordisk. The consortium, which was formed in early 2012, also sponsors the Medicon Valley Inhalation Symposium, and the 2nd iteration of the symposium will be held October 16, 2013 in Lund, Sweden.
